<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CONTEXT: Pediatric <z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">adrenocortical tumors</z:e> (ACTs) are rare and are frequently associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> predisposition syndromes </plain></SENT>
<SENT sid="1" pm="."><plain>Somatic GNAS1 mutations are associated with adrenocortical <z:mpath ids='MPATH_134'>hyperplasia</z:mpath>, but have not typically been reported in ACTs </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: We report on genetic and histopathological findings in a 3-month-old infant presenting with a unilateral <z:chebi fb="1" ids="17650">cortisol</z:chebi>-producing ACT with malignant features </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We performed a detailed clinical evaluation of the patient along with molecular genetic testing of genes associated with ACTs in both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue and peripheral lymphocytes </plain></SENT>
<SENT sid="4" pm="."><plain>We also performed a histopathological analysis of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The patient was found to have a p.R201C-activating mutation in exon 8 of the GNAS1 gene in <z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">adrenocortical tumor</z:e> tissue but not peripheral lymphocytes </plain></SENT>
<SENT sid="6" pm="."><plain>This mutation is the characteristic genetic change in <z:e sem="disease" ids="C0242292" disease_type="Disease or Syndrome" abbrv="POFD">McCune-Albright syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast to previously reported GNAS1-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> characterized by bimodal diffuse and nodular adrenocortical <z:mpath ids='MPATH_159'>hypertrophy</z:mpath>, our patient had a single adrenocortical mass that showed features of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, including areas of <z:mp ids='MP_0001651'>necrosis</z:mp>, microcystic degeneration, and venous and capsular microinvasion-changes that have been seen previously in <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>However, our patient did not have clinical features of <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Further analysis revealed abnormal allele-specific hypomethylation of the KCNQ1OT1 gene in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> sample but not peripheral lymphocytes </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: This is a novel case of an activating GNAS1 mutation associated with an epigenetic alteration that may be related to adrenocortical <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>Our findings may have implications in the molecular pathogenesis of pediatric ACTs </plain></SENT>
</text></document>